Intensive care unit (ICU) patients who received haloperidol (Haldol) for delirium fared no better on the AID-ICU trial's primary outcome at 3 months than those who received placebo. At 90 days, the ...
(HealthDay News) – In critically ill patients requiring ventilation, haloperidol treatment does not affect the amount of time alive without delirium or coma compared with placebo, according to a study ...
Haloperidol is a traditional or conventional antipsychotic used to treat schizophrenia, mania and other forms of psychosis. It is a derivative of butyrophenone and it acts by blocking the effects of ...
Haloperidol is an antipsychotic medication used to treat schizophrenia, mania and other forms of psychosis. It acts by blocking the effects of dopamine, a chemical in the brain that affects thinking, ...
SAN FRANCISCO – Haloperidol may be a better option than the old standby ondansetron to treat certain patients with vomiting and nausea in the emergency department (ED), according to a small ...
In a double-blind, placebo-controlled within-subjects design, participants received haloperidol (2 mg per 70 kg body weight, dose ranged from 1.8 to 2.7 mg) or placebo (saline solution) intravenously ...
In a randomized, phase II trial, patients were randomly assigned to receive either OLN 10 mg orally on days 1 to 4 or HAL 1 mg orally on day 1 and 0.5 mg twice daily on days 2 to 4. Both groups ...
Sensory gating is the brain’s ability to filter out irrelevant information before it reaches high levels of conscious processing. In the current study we aimed to investigate the involvement of the ...
As I sit on the couch in the cozy living room of my home, I hear a man’s low voice singing opera. It’s just far off enough that I can’t make out the lyrics. I also heard it last night while lying in ...
olaparib targets prostate cancer mutations Lorazepam plus haloperidol is more effective than haloperidol alone at reducing agitation, study finds. CHICAGO—Combination therapy with lorazepam and ...
Use of lorazepam-based regimens reduced persistent restlessness and agitation associated with end-of-life delirium in cancer patients, a randomized study showed. Among 72 patients in a palliative care ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback